Jak leczę chorego z rozpoznanym de novo chloniakiem z komórek plaszcza?
Author(s): Andrzej Deptala, Agnieszka Porowska
Treatment of mantle cell lymphoma is difficult due to lack of generally accepted standards for initial therapy. First-line chemotherapy even with rituximab is not curative despite providing frequent remissions of the disease. Therefore, remission consolidation strategies are mandatory for majority of patients. Remission consolidation with autologous hematopoietic stem cell transplantation improves the progression free survival, but is feasible only in a limited proportion of patients due to median age of diagnosis being 63 years. Patients ineligible for transplantation can benefit from radioimmunotherapy that is a valuable consolidative strategy. In this manuscript a comprehensive approach to initial treatment of mantle cell lymphoma is provided.
Share this article
Submitted PhD thesis in Biotechnology at GITAM University, Vizag.
The Past Head, General Administration of Pharmaceutical Care at Ministry of Health,
Saudi Arabia Critical Care/TPN
Clinical Pharmacist Ministry of Health,
Riyadh, Saudi Arabia.
Department of Radiation Oncology
Asahi University Hospital
Gifu city, Gifu, Japan
Maher Abdel Fattah Al-Shayeb
Department of Surgical Sciences, Ajman University, UAE
Institute of Gynecology and Obstetrics, Medical University of Lodz, I Clinic of Gynecology and Gynecological Oncology (Lodz, Poland)
Citations : 61
- Euro Pub
- Google Scholar
- Medical Project Poland
- Cancer Index
- Gdansk University of Technology, Ministry Points 20